PCK PainChek Limited
PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Returns
| 1 day | 1.1% |
| 1 week | -1.0% |
| 1 month | -8.6% |
| 3 months | -16.5% |
| 6 months | -31.4% |
| 1 year | -88.0% |
| 3 years | -83.5% |
Risk
| Volatility (1y ann.) | 92.0% |
| Beta vs ASX 200 | 0.88 |
| Sharpe (1y) | -1.89 |
| VaR 95% (1-day) | -9.4% |
| Max drawdown (1y) | -88.8% |
| Off 1-year high | -88.4% |
Technicals
| RSI(14) | 5 OS |
| vs 50DMA | -7.1% |
| vs 200DMA | -39.1% |
| Trend | Death cross |
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS-0.04
- Free cash flow—
- Net debt—